Contribute Try STAT+ Today

Good morning, everyone, and welcome to another working week. We hope the weekend respite was somehow relaxing and refreshing, given the dizzying developments outside your window. Now, of course, the relentless routine of Zoom meetings, Skype calls, and deadlines has returned, so time to get cracking. We are firing up the coffee kettle to brew another cup of stimulation — cinnamon mocha is our choice today — and, as always, we invite you to join us. Meanwhile, here is the latest menu of tidbits to help you get going. We hope today is productive, and meanwhile, stay safe — wear a mask. …

Pfizer (PFE) and its partner BioNTech (BNTX) reported that their Covid-19 vaccine was strongly effective, exceeding expectations with results that are likely to be met with cautious excitement — and relief — in the face of the global pandemic, STAT tells us. The vaccine is the first to be tested in the U.S. to generate late-stage data. The companies said an early analysis of results showed individuals who received two injections three weeks apart experienced more than 90% fewer cases of symptomatic Covid-19 than those who received a placebo.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.